ASCENSION CALUMET HOSPITAL — History
CCN 521317 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$32M
Latest Revenue (FY2022)
-0.6%
Revenue CAGR (3yr)
5.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $33M | $35M | $32M | -6.7% | -0.6% |
| Operating Expenses | $30M | $30M | $31M | +3.6% | +1.8% |
| Operating Margin | 9.6% | 14.6% | 5.2% | -64.8% | -26.7% |
| Net Income | $3M | $5M | $2M | -67.1% | -27.1% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,430 | 1,769 | 1,282 | -27.5% | -5.3% |
| Medicare Day % | 28% | 18% | 22% | +19.4% | -11.3% |
| Medicaid Day % | 0% | 0% | 3% | +911.9% | +395.4% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -1.2% ($33M → $32M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.6%
This Hospital
+7.6%
State Avg
Latest Margin
5.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $32M | 2.9% |
| FY2024 (proj) | $32M | 0.7% |
| FY2025 (proj) | $32M | -1.5% |